DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Commercial Services
Published
28 Sep 24
Updated
01 May 25
Views
42
Not Invested
DLH HoldingsDLHC
DLHC logo
Fair Value
US$10
Share price01 May
US$3.9160.9% undervalued intrinsic discount
Loading
1Y-30.30%
7D-0.51%

Federal Funding Improvements And Contract Challenges Will Shape Outlook

AN
AnalystConsensusTarget
AnalystConsensusTarget

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
28 Sep 24
Updated
01 May 25
Views
42
Not Invested
Fair ValueUS$10
Share priceUS$3.91
60.9% undervalued intrinsic discount
Narrative
Updates8

Last Update 01 May 25

Fair value Decreased 27%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Read more
1 viewusers have viewed this narrative update

Key Takeaways

  • Federal budget clarity, acquisition reforms, and digital transformation priorities are expected to boost DLH's contract wins, revenue growth, and margin expansion.
  • Increased demand for public health services and strong financial discipline enhance DLH's revenue stability, earnings potential, and ability to pursue growth opportunities.
  • Reliance on federal contracts, slowed procurement, customer concentration, tighter budgets, and margin compression threaten both revenue stability and earnings growth.

Catalysts

About DLH Holdings
    Provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States.
What are the underlying business or industry changes driving this perspective?
  • Improved clarity and increased funding in federal budgets for technology, cybersecurity, AI, and health IT programs are expected to accelerate government contract opportunities for DLH, positioning the company to capture new revenue streams as procurement activity picks up and RFP flow returns to normal levels in coming quarters-benefiting revenue growth.
  • The administration's new acquisition reforms are designed to speed contract approval and delivery, which should enable DLH to mitigate current revenue delays and win a larger share of rapidly awarded, high-value contracts-likely supporting both revenue and margin expansion.
  • DLH's ongoing investments in technology integration, internal R&D, and advanced analytical capabilities align with federal agencies' digital transformation priorities, supporting the company's ability to secure premium, higher-margin contracts and defend against margin pressures.
  • The continued expansion of public health and social programs, along with sustained federal focus on healthcare access and public health infrastructure, is expected to increase long-term demand for DLH's core service offerings, enhancing revenue visibility and supporting steady earnings growth.
  • Effective cost control, strong cash flow management, and accelerated debt reduction place DLH in a financially flexible position to capitalize on forthcoming growth opportunities, making it more resilient and likely to drive improved net margins and future earnings.
DLH Holdings Earnings and Revenue Growth

DLH Holdings Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming DLH Holdings's revenue will decrease by 28.2% annually over the next 3 years.
  • Analysts are not forecasting that DLH Holdings will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate DLH Holdings's profit margin will increase from 1.3% to the average US Professional Services industry of 7.1% in 3 years.
  • If DLH Holdings's profit margin were to converge on the industry average, you could expect earnings to reach $9.5 million (and earnings per share of $0.68) by about September 2028, up from $4.6 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 19.9x on those 2028 earnings, up from 17.8x today. This future PE is lower than the current PE for the US Professional Services industry at 26.3x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 10.58%, as per the Simply Wall St company report.
DLH Holdings Future Earnings Per Share Growth

DLH Holdings Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • DLH is experiencing ongoing revenue erosion due to the unbundling of contracts and the conversion of major VA and DoD programs to small business set-asides, shrinking its revenue base and heightening dependence on winning new business to offset these declines.
  • The flow of new RFPs, contract awards, and overall federal procurement activity has materially slowed, driven by administrative funding reviews, approval delays, and cuts to government acquisition personnel, which limits DLH's visibility into future revenue growth and extends sales cycles.
  • The company remains exposed to high customer concentration risk, as evidenced by the impending transition of a major CMOP site (approximately $10 million in annual revenue) and uncertainty around contract renewals for the remaining sites, directly threatening both short-term and potential long-term revenue stability.
  • Increasing tightening of federal budgets, administrative policy shifts, and efficiency-driven narrowing of contract scopes have already resulted in lost revenue and could further constrain DLH's addressable market, putting pressure on both revenue and margins as the company may have to compete more aggressively.
  • Despite scaling costs in response to lower volume, EBITDA margins have compressed year-over-year (from 10% to 9.7%) and continued pressure to invest in technology, compliance, and pricing concessions to win contracts may exacerbate margin erosion, dampening future earnings growth.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of $10.0 for DLH Holdings based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $133.3 million, earnings will come to $9.5 million, and it would be trading on a PE ratio of 19.9x, assuming you use a discount rate of 10.6%.
  • Given the current share price of $5.65, the analyst price target of $10.0 is 43.5% higher. Despite analysts expecting the underlying buisness to decline, they seem to believe it's more valuable than what the market thinks.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on DLH Holdings?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

There are no other narratives for this company.
View all narratives

Fair Value vs Share Price

US$10
vs US$3.9160.9% undervalued intrinsic discount
PastFuture0396m2014201720202023202520262028Revenue US$133.3mEarnings US$9.5m
-28.2%
Revenue growth
7.1%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on DLH Holdings

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Good value with very low risk.

Market capUS$56.7m
PB0.6x
Estimated Growth-25.7%
Dividend YieldN/A
Full analysis

CEO & management

Kathryn JohnBull
CEO
0.3yrs
CEO Tenure

Provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide